To lower the cost of expensive drugs, Biden targets Big Pharma’s patents

By The Nevadan Staff

December 20, 2023

The Biden administration is putting pharmaceutical companies on notice, warning them that if the price of certain drugs is too high, the government might cancel their patent protection and allow rivals to make their own versions. Our correspondent @ogofthehrc has the details and you can read more here:

♬ original sound – NevadanNews



Local News

Related Stories
Share This